Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IRINOTECAN Cause Activated partial thromboplastin time prolonged? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Activated partial thromboplastin time prolonged have been filed in association with IRINOTECAN (Irinotecan Hydrochloride). This represents 0.0% of all adverse event reports for IRINOTECAN.

6
Reports of Activated partial thromboplastin time prolonged with IRINOTECAN
0.0%
of all IRINOTECAN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From IRINOTECAN?

Of the 6 reports, 2 (33.3%) required hospitalization.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IRINOTECAN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does IRINOTECAN Cause?

Diarrhoea (4,157) Neutropenia (2,533) Nausea (2,374) Disease progression (2,018) Off label use (2,018) Vomiting (1,944) Fatigue (1,515) Febrile neutropenia (1,357) Anaemia (1,231) Thrombocytopenia (1,214)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which IRINOTECAN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

IRINOTECAN vs IRON IRINOTECAN vs IRON DEXTRAN IRINOTECAN vs IRON ISOMALTOSIDE 1000 IRINOTECAN vs IRON POLYMALTOSE IRINOTECAN vs IRON SUCROSE

Related Pages

IRINOTECAN Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged IRINOTECAN Demographics